SCHERING logo 228 (Fulvicin P/G ultramicrocrystalline 125 mg)
Generic Name: griseofulvin
Pill with imprint SCHERING logo 228 is White, Round and has been identified as Fulvicin P/G ultramicrocrystalline 125 mg. It is supplied by Schering-Plough Corporation.
Fulvicin P/G is used in the treatment of dermatophytosis; tinea barbae; onychomycosis, toenail; onychomycosis, fingernail; tinea capitis and belongs to the drug class miscellaneous antifungals. Risk cannot be ruled out during pregnancy. Fulvicin P/G ultramicrocrystalline 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for SCHERING logo 228
Fulvicin P/G
- Generic Name
- griseofulvin
- Imprint
- SCHERING logo 228
- Strength
- ultramicrocrystalline 125 mg
- Color
- White
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Miscellaneous antifungals
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Schering-Plough Corporation
- National Drug Code (NDC)
- 00085-0228 (Discontinued)
More about Fulvicin P/G (griseofulvin)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Drug class: miscellaneous antifungals
Patient resources
- Other brands
- Grifulvin V, Fulvicin U/F, Gris-PEG
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.